Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 3,061 | 653 | 679 | 1,678 | 1,587 |
| Gross Profit | 3,061 | 653 | 679 | 1,678 | 1,587 |
| Operating Expenses | 94,086 | 21,168 | 19,750 | 18,581 | 34,013 |
| Operating Income | -91,025 | -20,515 | -19,071 | -16,903 | -32,426 |
| Interest Expense | 1,100 | 2 | 12 | 122 | 0 |
| Other Income | -3,034 | -2,798 | -4,168 | -1,224 | 3,671 |
| Pre-tax Income | -95,159 | -23,315 | -23,251 | -18,249 | -28,755 |
| Income Tax | -12,656 | N/A | N/A | N/A | -4,282 |
| Net Income Continuous | -82,503 | -23,315 | -23,251 | -18,249 | -24,473 |
| Net Income | $-82,503 | $-23,315 | $-23,251 | $-18,249 | $-24,473 |
| EPS Basic Total Ops | -1.50 | -0.46 | -0.47 | -0.37 | -0.49 |
| EPS Basic Continuous Ops | -1.45 | -0.41 | -0.42 | -0.33 | -0.44 |
| EPS Diluted Total Ops | -1.50 | -0.46 | -0.47 | -0.37 | -0.49 |
| EPS Diluted Continuous Ops | -1.45 | -0.41 | -0.42 | -0.33 | -0.44 |
| EBITDA(a) | $-24,211 | $-20,010 | $-18,562 | $-16,399 | $-17,118 |